Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

OrthoPediatrics stock

KIDS
US68752L1008
A2JAAV

Price

24.07
Today +/-
+1.19
Today %
+5.38 %
P

OrthoPediatrics stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the OrthoPediatrics stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the OrthoPediatrics stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the OrthoPediatrics stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze OrthoPediatrics's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

OrthoPediatrics Stock Price History

DateOrthoPediatrics Price
11/19/202424.07 undefined
11/18/202422.81 undefined
11/15/202422.93 undefined
11/14/202422.69 undefined
11/13/202424.53 undefined
11/12/202424.04 undefined
11/11/202424.98 undefined
11/8/202425.72 undefined
11/7/202427.49 undefined
11/6/202430.95 undefined
11/5/202429.81 undefined
11/4/202428.74 undefined
11/1/202427.36 undefined
10/31/202426.53 undefined
10/30/202427.00 undefined
10/29/202426.59 undefined
10/28/202426.13 undefined
10/25/202425.69 undefined
10/24/202425.61 undefined
10/23/202425.82 undefined
10/22/202426.66 undefined
10/21/202426.72 undefined

OrthoPediatrics Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into OrthoPediatrics, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OrthoPediatrics from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OrthoPediatrics’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of OrthoPediatrics. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into OrthoPediatrics’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing OrthoPediatrics’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OrthoPediatrics’s growth potential.

OrthoPediatrics Revenue, EBIT and net profit per share

DateOrthoPediatrics RevenueOrthoPediatrics EBITOrthoPediatrics Net Income
2026e287.14 M undefined-12.5 M undefined-15.91 M undefined
2025e244.87 M undefined-21.16 M undefined-25.28 M undefined
2024e206.32 M undefined-28.33 M undefined-29.6 M undefined
2023148.73 M undefined-25.77 M undefined-20.97 M undefined
2022122.3 M undefined-21.4 M undefined1.3 M undefined
202198 M undefined-17.5 M undefined-16.3 M undefined
202071.1 M undefined-19.5 M undefined-32.9 M undefined
201972.6 M undefined-8.4 M undefined-13.7 M undefined
201857.6 M undefined-9.6 M undefined-12 M undefined
201745.6 M undefined-6.5 M undefined-23.5 M undefined
201637.3 M undefined-4.1 M undefined-12.4 M undefined
201531 M undefined-6.6 M undefined-12.7 M undefined
201423.7 M undefined-7.1 M undefined-12.8 M undefined

OrthoPediatrics Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)NET INCOME (k)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
20142015201620172018201920202021202220232024e2025e2026e
2331374557727198122148206244287
-34.7819.3521.6226.6726.32-1.3938.0324.4921.3139.1918.4517.62
69.5767.7470.2775.5673.6875.0077.4674.4973.7775.0053.8845.4938.68
162126344254557390111000
-12,000-12,000-12,000-23,000-12,000-13,000-32,000-16,0001,000-20,000-29,000-25,000-15,000
---91.67-47.838.33146.15-50.00-106.25-2,100.0045.00-13.79-40.00
12121212.812.614.618.119.320.922.68000
-------------
Details

Keystats

ⓘ

Revenue and Growth

The OrthoPediatrics Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the OrthoPediatrics is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (k)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (k)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
2014201520162017201820192020202120222023
                   
6.63.91.642.660.770.883.953.5118.380.31
2.83.84.15.691617.217.924.834.62
0000500600300000
17.314.614.920.525.7385357.678.2105.85
0.90.20.20.81.32.844.65.55.72
27.622.520.869.597.2128.2158.4133.6226.8226.5
7.57.38.610.412.821.327.228.534.341.05
0000000000
0000000000
0.90.91.32.32.21964.269.879.984.56
0000013.870.572.386.883.7
0000000002.94
8.48.29.912.71554.1161.9170.6201212.25
3630.730.782.2112.2182.3320.3304.2427.8438.75
                   
60.665.471.30000000.01
2117.412.8150.4197.4271.2388.6394.9560.8580.29
-63.7-71.6-78.1-103.1-115.1-128.8-161.8-178-176.8-197.74
0000.1-0.607.98.5-5.4-5.53
0000000000
17.911.2647.481.7142.4234.7225.4378.6377.03
0.623.55.546.5109.311.212.65
1.52.32.22.93.64.310.95.46.711.33
121.411.62.71414.912.817.54
0000000000
100100100100100100100100100152
3.26.47.29.59.313.63529.730.841.67
14.61317.425.321.226.110.90.89.91
0000005.84.865.48
000000.143.843.511.54.66
14.61317.425.321.226.250.649.218.320.05
17.819.424.634.830.539.885.678.949.161.72
35.730.630.682.2112.2182.2320.3304.3427.7438.75
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of OrthoPediatrics provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand OrthoPediatrics's financial health and stability.

Assets

OrthoPediatrics's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that OrthoPediatrics must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of OrthoPediatrics after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into OrthoPediatrics's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (k)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
2014201520162017201820192020202120222023
-9,000-7,000-6,000-8,000-12,000-13,000-32,000-16,0001,000-20,000
1112248101317
0000000-1-5-1
-243-4-9-11-4-12-17-32
1106651812-620
2112241000
0000000000
-90-1-7-15-17-18-13-21-27
-3-2-4-6-5-12-11-16-10-18
-3-1-4-6-5-61-69-7-11341
00000-49-588-10360
0000000000
2047-429-25009
16005343617101390
19035439914601357
---------3.00-2.00
000-5000000
6-2-2401811-41-21122
-13.24-3.14-5.87-13.76-21.04-29.86-29.83-29.07-31.8-46.03
0000000000

OrthoPediatrics stock margins

The OrthoPediatrics margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OrthoPediatrics. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OrthoPediatrics.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the OrthoPediatrics's sales revenue. A higher gross margin percentage indicates that the OrthoPediatrics retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the OrthoPediatrics's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the OrthoPediatrics's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OrthoPediatrics's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OrthoPediatrics. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OrthoPediatrics's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

OrthoPediatrics Margin History

OrthoPediatrics Gross marginOrthoPediatrics Profit marginOrthoPediatrics EBIT marginOrthoPediatrics Profit margin
2026e74.8 %-4.35 %-5.54 %
2025e74.8 %-8.64 %-10.32 %
2024e74.8 %-13.73 %-14.35 %
202374.8 %-17.32 %-14.1 %
202274.16 %-17.5 %1.06 %
202174.9 %-17.86 %-16.63 %
202077.36 %-27.43 %-46.27 %
201975.21 %-11.57 %-18.87 %
201874.13 %-16.67 %-20.83 %
201775.66 %-14.25 %-51.54 %
201670.78 %-10.99 %-33.24 %
201569.68 %-21.29 %-40.97 %
201470.04 %-29.96 %-54.01 %

OrthoPediatrics Stock Sales Revenue, EBIT, Earnings per Share

The OrthoPediatrics earnings per share therefore indicates how much revenue OrthoPediatrics has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OrthoPediatrics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OrthoPediatrics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OrthoPediatrics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OrthoPediatrics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

OrthoPediatrics Revenue, EBIT and net profit per share

DateOrthoPediatrics Sales per ShareOrthoPediatrics EBIT per shareOrthoPediatrics Earnings per Share
2026e11.86 undefined0 undefined-0.66 undefined
2025e10.11 undefined0 undefined-1.04 undefined
2024e8.52 undefined0 undefined-1.22 undefined
20236.56 undefined-1.14 undefined-0.92 undefined
20225.85 undefined-1.02 undefined0.06 undefined
20215.08 undefined-0.91 undefined-0.84 undefined
20203.93 undefined-1.08 undefined-1.82 undefined
20194.97 undefined-0.58 undefined-0.94 undefined
20184.57 undefined-0.76 undefined-0.95 undefined
20173.56 undefined-0.51 undefined-1.84 undefined
20163.11 undefined-0.34 undefined-1.03 undefined
20152.58 undefined-0.55 undefined-1.06 undefined
20141.98 undefined-0.59 undefined-1.07 undefined

OrthoPediatrics business model

OrthoPediatrics Corp is an American company specializing in products and solutions for orthopedic disorders in children and adolescents. The company was founded in 2006 and is headquartered in Warsaw, Indiana. Business model: The business model of OrthoPediatrics Corp focuses on the development and marketing of implants and surgical instruments for the treatment of orthopedic disorders in children and adolescents. The company works closely with specialists and hospitals to develop innovative and specialized products that meet the needs of children and adolescents. The company specializes in three areas: 1. Trauma and deformity correction – treatment of spinal and limb injuries as well as congenital deformity disorders in children and adolescents. 2. Scoliosis and spinal surgery – correction of spinal deformity and treatment of scoliosis and kyphosis in children and adolescents. 3. Sports medicine and orthobiology – development of solutions to support bone healing and regeneration in children and adolescents after an injury or surgery. Products: OrthoPediatrics Corp offers a variety of products tailored to the specific needs and requirements of children and adolescents. These include: - Bands and implants for repairing broken bones and joint injuries. - Surgical instruments and implants for correcting spinal and limb deformities such as scoliosis. - Technologies to promote bone healing and regeneration, such as BioCartilage and Pedigree matrix. OrthoPediatrics Corp also has partnerships with other companies, such as Bioretec and PhyzioMedics, to develop innovative products and solutions that meet the needs of children and adolescents. Conclusion: OrthoPediatrics Corp is a leading provider of orthopedic solutions for children and adolescents. The company has a long history and an excellent reputation for developing innovative products and solutions tailored to the specific needs and requirements of this age group. The company works closely with specialists and hospitals to ensure that its products meet the highest medical standards and effectively help patients. OrthoPediatrics is one of the most popular companies on Eulerpool.com.

OrthoPediatrics SWOT Analysis

Strengths

OrthoPediatrics Corp is known for its continuous product innovation in the field of pediatric orthopedics. This strength allows the company to stay competitive and cater to the unique needs of pediatric patients.

With a focus solely on pediatric orthopedics, OrthoPediatrics Corp has established itself as a leader in this niche market. This specialization enables the company to provide highly specialized and targeted solutions to its customers.

Weaknesses

OrthoPediatrics Corp relies heavily on a few key customers for a significant portion of its revenue. This dependence poses a risk, as any loss of these customers could have a substantial negative impact on the company's financial performance.

Despite its success in the domestic market, OrthoPediatrics Corp has a relatively limited global presence compared to some of its competitors. This limited reach may restrict the company's growth opportunities in international markets.

Opportunities

There is a growing demand for pediatric orthopedic solutions due to an increasing focus on children's health and well-being. OrthoPediatrics Corp can take advantage of this opportunity by further expanding its product offerings and targeting new customer segments.

OrthoPediatrics Corp can explore expansion opportunities in emerging markets, where there is a rising need for specialized orthopedic solutions for children. By entering these markets early, the company can gain a competitive advantage and establish a strong presence.

Threats

The pediatric orthopedic industry is highly competitive, with numerous players competing for market share. OrthoPediatrics Corp faces the threat of intense competition, which could potentially impact its market position and profitability.

The healthcare industry is subject to various regulations and compliance requirements. OrthoPediatrics Corp may face challenges in navigating these regulations, which could result in increased costs and delays in product approvals.

OrthoPediatrics Revenue by Segment

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OrthoPediatrics Revenue by Segment

Segmente2023202220212020201920182017
Trauma and deformity106.78 M USD85.06 M USD-----
Scoliosis37.93 M USD33.43 M USD-----
Sports medicine/other4.02 M USD3.81 M USD-----

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OrthoPediatrics Revenue by Segment

Segmente2023202220212020201920182017
Trauma and deformity--65.83 M USD----
Scoliosis--28.05 M USD----
Sports medicine/other--4.17 M USD----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OrthoPediatrics Revenue by Segment

Segmente2023202220212020201920182017
Trauma and deformity---47.68 M USD49.37 M USD39.7 M USD-
Scoliosis---20.74 M USD21.49 M USD16.66 M USD-
Sports medicine/other---2.66 M USD1.7 M USD1.2 M USD-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OrthoPediatrics Revenue by Segment

Segmente2023202220212020201920182017
Trauma and deformity------32.8 M USD
Scoliosis------11.59 M USD
Sports medicine/other------1.23 M USD

OrthoPediatrics Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

OrthoPediatrics Revenue by Segment

DateInternationalU.S
202337.72 M USD111.01 M USD
202229.87 M USD92.42 M USD
201710.71 M USD34.91 M USD
LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OrthoPediatrics Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

OrthoPediatrics historical P/E ratio, EBIT multiple, and P/S ratio

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OrthoPediatrics shares outstanding

The number of shares was OrthoPediatrics in 2023 — This indicates how many shares 22.675 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OrthoPediatrics earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OrthoPediatrics's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OrthoPediatrics’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OrthoPediatrics's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

LIMITED TIME OFFER

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for OrthoPediatrics.

OrthoPediatrics latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2024-0.25 -0.34  (-38.32 %)2024 Q3
6/30/2024-0.28 -0.26  (6.91 %)2024 Q2
3/31/2024-0.41 -0.34  (17.58 %)2024 Q1
12/31/2023-0.29 -0.29  (-1.4 %)2023 Q4
9/30/2023-0.23 -0.2  (12.02 %)2023 Q3
6/30/2023-0.22 -0.13  (41.07 %)2023 Q2
3/31/2023-0.37 -0.3  (19.4 %)2023 Q1
12/31/2022-0.26 -0.35  (-35.71 %)2022 Q4
9/30/2022-0.21 -0.07  (66.38 %)2022 Q3
6/30/2022-0.22 -0.02  (90.85 %)2022 Q2
1
2
3

Eulerpool ESG Scorecard© for the OrthoPediatrics stock

Eulerpool World ESG Rating (EESG©)

30/ 100

🌱 Environment

35

👫 Social

46

🏛️ Governance

9

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
179
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

OrthoPediatrics shareholders

%
Name
Stocks
Change
Date
28.49614 % Squadron Capital LLC6,901,76404/4/2024
10.70920 % Brown Capital Management, LLC2,593,768-197,9356/30/2024
6.67566 % Brown Advisory1,616,846-31,5926/30/2024
4.57378 % Braidwell LP1,107,77006/30/2024
4.56436 % BlackRock Institutional Trust Company, N.A.1,105,48854,2726/30/2024
4.12333 % Granahan Investment Management, LLC998,670272,5516/30/2024
3.74191 % The Vanguard Group, Inc.906,29024,7546/30/2024
3.13945 % Wellington Management Company, LLP760,37528,8006/30/2024
2.21014 % Wasatch Global Investors Inc535,29633,9866/30/2024
1.93663 % Dimensional Fund Advisors, L.P.469,051-37,7696/30/2024
1
2
3
4
5
...
10

OrthoPediatrics Executives and Management Board

Mr. David Bailey(44)
OrthoPediatrics President, Chief Executive Officer, Director (since 2009)
Compensation 1.28 M
Mr. Fred Hite(55)
OrthoPediatrics Chief Financial Officer, Chief Operating Officer, Director (since 2015)
Compensation 1.26 M
Mr. Gregory Odle(53)
OrthoPediatrics President of Scoliosis
Compensation 1.05 M
Mr. Joseph Hauser(41)
OrthoPediatrics President of Trauma and Deformity Correction
Compensation 1.02 M
Mr. Daniel Gerritzen(53)
OrthoPediatrics Executive Vice President - Legal, General Counsel, Company Secretary
Compensation 1.02 M
1
2
3

Most common questions regarding OrthoPediatrics

What values and corporate philosophy does OrthoPediatrics represent?

OrthoPediatrics Corp represents values of innovation, integrity, and commitment to improving pediatric orthopedic care. The company's corporate philosophy revolves around providing advanced solutions to address the unique needs of children, ensuring positive outcomes and improved quality of life. OrthoPediatrics Corp's focus on research and development, collaborative partnerships, and the highest standards of patient care showcases their strong commitment to advancing pediatric orthopedics. By leveraging cutting-edge technology and expertise, OrthoPediatrics Corp strives to enhance surgical procedures, develop innovative implants and instruments, and ultimately make a significant difference in the lives of pediatric patients worldwide.

In which countries and regions is OrthoPediatrics primarily present?

OrthoPediatrics Corp is primarily present in the United States.

What significant milestones has the company OrthoPediatrics achieved?

OrthoPediatrics Corp has achieved several significant milestones. Since its inception, the company has demonstrated strong growth and innovation. It became the first company to develop a comprehensive pediatric-specific surgical implant offering. OrthoPediatrics Corp has successfully introduced advanced implants and instruments specifically designed for pediatric orthopedic surgery, addressing unmet medical needs. The company has also expanded globally, establishing a presence in over 50 countries, which has further contributed to its success. OrthoPediatrics Corp continues to pioneer in pediatric orthopedics, providing specialized solutions that improve the quality of care for children with musculoskeletal conditions.

What is the history and background of the company OrthoPediatrics?

OrthoPediatrics Corp is a leading orthopedic company specializing in pediatric orthopedic medical devices and technologies. Founded in 2006, the company has established itself as a prominent player in the market, catering exclusively to the unique needs of children. OrthoPediatrics Corp focuses on developing innovative solutions that address a wide range of orthopedic conditions in pediatric patients. With an extensive product portfolio and a strong commitment to research and development, the company has continuously expanded its presence globally. OrthoPediatrics Corp's dedication to improving the lives of children through orthopedic advancements has earned it a reputable standing in the industry.

Who are the main competitors of OrthoPediatrics in the market?

Some of the main competitors of OrthoPediatrics Corp in the market include Zimmer Biomet Holdings Inc., Johnson & Johnson, and Stryker Corporation.

In which industries is OrthoPediatrics primarily active?

OrthoPediatrics Corp is primarily active in the medical device industry, specifically focusing on orthopedic products and solutions for children.

What is the business model of OrthoPediatrics?

The business model of OrthoPediatrics Corp revolves around designing, developing, and selling of orthopedic implants and instruments specifically for children. OrthoPediatrics focuses on serving the needs of healthcare professionals who specialize in pediatric orthopedics by offering a comprehensive product portfolio. They aim to improve the quality of life for children with orthopedic conditions, providing innovative solutions tailored to their unique and growing anatomies. OrthoPediatrics' business model is centered on delivering specialized pediatric orthopedic implants, surgical instruments, and related services, thereby catering to the specific requirements of pediatric patients and addressing a niche market in the medical industry.

What is the P/E ratio of OrthoPediatrics 2024?

The OrthoPediatrics P/E ratio is -18.44.

What is the P/S ratio of OrthoPediatrics 2024?

The OrthoPediatrics P/S ratio is 2.65.

What is the Quality Investing of OrthoPediatrics?

The Quality Investing for OrthoPediatrics is 4/10.

What is the revenue of OrthoPediatrics 2024?

The expected OrthoPediatrics revenue is 206.32 M USD.

How high is the profit of OrthoPediatrics 2024?

The expected OrthoPediatrics profit is -29.6 M USD.

What is the business model of OrthoPediatrics

OrthoPediatrics Corp is a global provider of orthopedic implants and instruments for the pediatric market. The company was founded in 2006 and is headquartered in the USA. Its goal is to support children and adolescents with orthopedic conditions and enable them to lead active lives. The company has three different business areas: Products, Operative Services, and Education Services. In the Products area, OrthoPediatrics Corp offers a wide range of implants and instruments specifically designed for the treatment of children and adolescents. They offer over 30 surgical systems that can be used for a variety of diagnoses such as scoliosis, hip dysplasia, or fractures. A significant product that OrthoPediatrics Corp offers is the Pediatric Nailing System, a central technology used to manufacture many of their surgical systems. This system is specifically designed for the needs of children and adolescents and facilitates quick and accurate treatment for surgeons. Operative Services is the second business area of OrthoPediatrics Corp. Here, the company offers a variety of service options tailored to the needs of children and adolescents. This includes support for surgery planning, delivery of instruments and implants to the operating site, and providing training for medical personnel. The third business area of OrthoPediatrics Corp is education. The company offers a variety of training programs to educate doctors and medical personnel on the latest technologies and treatment methods for children and adolescents. OrthoPediatrics Corp aims to train doctors and medical personnel on handling children and adolescents through workshops, seminars, and training sessions for doctors, nurses, and other medical staff. OrthoPediatrics Corp's business model is based on the belief that there are no simple operations for children and adolescents. Therefore, the company has developed products and services that consider the specific needs of children and adolescents. The company pursues a strong brand strategy in the pediatric orthopedics market and has established a strong presence in this field. OrthoPediatrics Corp aims to further expand its market position and plans to focus strongly on international markets in the coming years. The company works closely with medical facilities, surgeons, and hospitals to provide advanced technology, excellent service, and training. OrthoPediatrics Corp will continue to be a strong partner for healthcare in the future to ensure that children and adolescents receive the best possible treatment outcomes.

What is the OrthoPediatrics dividend?

OrthoPediatrics pays a dividend of 0 USD distributed over payouts per year.

How often does OrthoPediatrics pay dividends?

The dividend cannot currently be calculated for OrthoPediatrics or the company does not pay out a dividend.

What is the OrthoPediatrics ISIN?

The ISIN of OrthoPediatrics is US68752L1008.

What is the OrthoPediatrics WKN?

The WKN of OrthoPediatrics is A2JAAV.

What is the OrthoPediatrics ticker?

The ticker of OrthoPediatrics is KIDS.

How much dividend does OrthoPediatrics pay?

Over the past 12 months, OrthoPediatrics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OrthoPediatrics is expected to pay a dividend of 0 USD.

What is the dividend yield of OrthoPediatrics?

The current dividend yield of OrthoPediatrics is .

When does OrthoPediatrics pay dividends?

OrthoPediatrics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OrthoPediatrics?

OrthoPediatrics paid dividends every year for the past 0 years.

What is the dividend of OrthoPediatrics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OrthoPediatrics located?

OrthoPediatrics is assigned to the 'Health' sector.

Wann musste ich die Aktien von OrthoPediatrics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OrthoPediatrics from 11/20/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/20/2024.

When did OrthoPediatrics pay the last dividend?

The last dividend was paid out on 11/20/2024.

What was the dividend of OrthoPediatrics in the year 2023?

In the year 2023, OrthoPediatrics distributed 0 USD as dividends.

In which currency does OrthoPediatrics pay out the dividend?

The dividends of OrthoPediatrics are distributed in USD.

All fundamentals about OrthoPediatrics

Our stock analysis for OrthoPediatrics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OrthoPediatrics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.